Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, please find enclosed herewith Newspaper Publication regarding Meeting of the Board of Directors of the Company scheduled to be ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gennex Laboratories has informed stock exchanges about a Board of Directors meeting scheduled for Friday, November 14, 2025, at its Hyderabad corporate office. The Board will consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2025, along with the Limited Review Report of the Statutory Auditors. The company published this notice in Business Standard (English) and Saksham (Telugu local) on November 05, 2025, in compliance with SEBI's Listing Regulations. This is a standard regulatory disclosure and does not contain any new business or financial information on its own.
This is a routine compliance filing with no direct impact on the stock price. Investors should watch for the actual Q2/H1 FY26 results due on or after November 14, 2025, as the numbers themselves will be the catalyst for any price movement.